» Articles » PMID: 25566502

The Host Microenvironment Influences Prostate Cancer Invasion, Systemic Spread, Bone Colonization, and Osteoblastic Metastasis

Overview
Journal Front Oncol
Specialty Oncology
Date 2015 Jan 8
PMID 25566502
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Prostate cancer (PCa) is the second leading cause of cancer death in men worldwide. Most PCa deaths are due to osteoblastic bone metastases. What triggers PCa metastasis to the bone and what causes osteoblastic lesions remain unanswered. A major contributor to PCa metastasis is the host microenvironment. Here, we address how the primary tumor microenvironment influences PCa metastasis via integrins, extracellular proteases, and transient epithelia-mesenchymal transition (EMT) to promote PCa progression, invasion, and metastasis. We discuss how the bone-microenvironment influences metastasis; where chemotactic cytokines favor bone homing, adhesion molecules promote colonization, and bone-derived signals induce osteoblastic lesions. Animal models that fully recapitulate human PCa progression from primary tumor to bone metastasis are needed to understand the PCa pathophysiology that leads to bone metastasis. Better delineation of the specific processes involved in PCa bone metastasize is needed to prevent or treat metastatic PCa. Therapeutic regimens that focus on the tumor microenvironment could add to the PCa pharmacopeia.

Citing Articles

Obesity, dietary interventions and microbiome alterations in the development and progression of prostate cancer.

Trecarten S, Liss M, Hamilton-Reeves J, DiGiovanni J Front Immunol. 2025; 15():1448116.

PMID: 39840030 PMC: 11747771. DOI: 10.3389/fimmu.2024.1448116.


Microbiota and the landscape of the prostate tumor microenvironment.

Gupta K, Kyprianou N Am J Clin Exp Urol. 2023; 11(5):352-360.

PMID: 37941651 PMC: 10628624.


MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis.

Maji S, Pradhan A, Kumar A, Bhoopathi P, Mannangatti P, Guo C Proc Natl Acad Sci U S A. 2023; 120(45):e2307094120.

PMID: 37922327 PMC: 10636346. DOI: 10.1073/pnas.2307094120.


Mechanism of regulating macrophages/osteoclasts in attenuating wear particle-induced aseptic osteolysis.

Yin Z, Gong G, Liu X, Yin J Front Immunol. 2023; 14:1274679.

PMID: 37860014 PMC: 10582964. DOI: 10.3389/fimmu.2023.1274679.


SEMA4A promotes prostate cancer invasion: involvement of tumor microenvironment.

Liu X, Tan W, Wang W, Feng T, Wang C, Wang L J Cancer. 2023; 14(14):2633-2643.

PMID: 37779872 PMC: 10539395. DOI: 10.7150/jca.86739.


References
1.
Heldin C . Targeting the PDGF signaling pathway in tumor treatment. Cell Commun Signal. 2013; 11:97. PMC: 3878225. DOI: 10.1186/1478-811X-11-97. View

2.
Sullivan D, Ferris M, Nguyen H, Abboud E, Brody A . TNF-alpha induces TGF-beta1 expression in lung fibroblasts at the transcriptional level via AP-1 activation. J Cell Mol Med. 2010; 13(8B):1866-76. PMC: 2855747. DOI: 10.1111/j.1582-4934.2009.00647.x. View

3.
Iqbal N, Iqbal N . Imatinib: a breakthrough of targeted therapy in cancer. Chemother Res Pract. 2014; 2014:357027. PMC: 4055302. DOI: 10.1155/2014/357027. View

4.
Fornaro M, Tallini G, Zheng D, Flanagan W, Manzotti M, Languino L . p27(kip1) acts as a downstream effector of and is coexpressed with the beta1C integrin in prostatic adenocarcinoma. J Clin Invest. 1999; 103(3):321-9. PMC: 407898. DOI: 10.1172/JCI4585. View

5.
Chen G, Shukeir N, Potti A, Sircar K, Aprikian A, Goltzman D . Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications. Cancer. 2004; 101(6):1345-56. DOI: 10.1002/cncr.20518. View